Fortis Healthcare Limited — Others, 07-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

Fortis Healthcare Limited has announced a board meeting to discuss the utilization of proceeds from its recent private placement of Non-Convertible Debentures (NCDs), raising ₹1,550 crore. As of December 31, 2024, ₹429.37 crore has been utilized, with no deviations noted in the fund usage. The company plans to purchase equity shares of Agilus Diagnostics Limited and cover issue-related expenses. This transparency could bolster investor confidence, as it indicates accountability in fund management without any shifts in strategic intent, pointing towards a stable financial outlook.